Depsides as non-redox inhibitors of leukotriene B-4 biosynthesis and HaCaT cell growth, 2. Novel analogues of obtusatic acid

Kumar, Sunil and Mueller, Klaus (2000) Depsides as non-redox inhibitors of leukotriene B-4 biosynthesis and HaCaT cell growth, 2. Novel analogues of obtusatic acid. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 35 (4). pp. 405-411. ISSN 0223-5234, 1768-3254

Full text not available from this repository. (Request a copy)

Abstract

A series of obtusatic acid analogues has been synthesized and evaluated as inhibitors of leukotriene B-4 (LTB4) biosynthesis and as antiproliferative agents. The 4-O-benzylated and the 4-O-demethylated congeners were the most potent inhibitors of LTB4 production of the depside class of compounds, with IC50 values in the submicromolar range. Furthermore, these compounds do not function as redox-based inhibitors because they were not reactive against a stable free radical, 2,2-diphenyl-1-picrylhydrazyl, and did not produce appreciable amounts of deoxyribose degradation as a measure of their potency to generate hydroxyl radicals. Some obtusatic acid congeners were also potent inhibitors of keratinocyte growth. Growth inhibition was not mediated by damage to the cell membrane, as the activity of lactate dehydrogenase released from the cytoplasm was in the control range. (C) 2000 Editions scientifiques et medicales Elsevier SAS.

Item Type: Article
Uncontrolled Keywords: ANTIPSORIATIC ANTHRONES; KERATINOCYTE GROWTH; LICHEN METABOLITES; 5-LIPOXYGENASE; 1,8-DIHYDROXY-9(10H)-ANTHRACENONES; INACTIVATION; DERIVATIVES; ANTHRALIN; RADICALS; TARGET; antiproliferative activity; keratinocytes; lactate dehydrogenase release; leukotriene biosynthesis; obtusatic acid
Subjects: 600 Technology > 615 Pharmacy
Divisions: Chemistry and Pharmacy > Institute of Pharmacy > Pharmaceutical/Medicinal Chemistry I (Prof. Elz)
Depositing User: Dr. Gernot Deinzer
Date Deposited: 17 May 2022 13:24
Last Modified: 17 May 2022 13:24
URI: https://pred.uni-regensburg.de/id/eprint/42620

Actions (login required)

View Item View Item